UNASSIGNED: One of the common causes of failure in dacryocystorhinostomy for nasolacrimal duct obstruction (NLDO) is @entity33 and @entity82 around the ostium. @entity479 and @entity1138 ( @entity1139 ) can potentially reduce scarring by their action on the inflammatory and proliferative phase of wound healing, respectively. The purpose of this study is to evaluate the safety and efficacy of combined usage of adjunctive @entity1139 and intranasal @entity2713 (TA) in endonasal endoscopic dacryocystorhinostomy (EE-DCR). This is a retrospective interventional case series. All @entity1 underwent mechanical EE-DCR in two regional hospitals in Hong Kong from January 2005 to December 2006 were included. All received intraoperative @entity1139 application for 5  min and gelfoam soaked with TA onto the ostium. Main outcome measures include the anatomical and functional success rate at follow-up at least 6  months after operation. Other outcomes include @entity532 occurred during and after operation. A total of 73 EE-DCR were performed in 69 @entity1 . Three @entity1 had simultaneous bilateral DCR; one had sequential DCRs for both sides. At the last follow-up, anatomical success was achieved in 68 cases (93  %) and both anatomical with functional success in 67 cases (92  %). No major complication was observed. Minor @entity532 included asymptomatic @entity33 between the nasal septum and lateral nasal wall in one @entity1 and moderate secondary @entity548 in another. EE-DCR with adjunctive @entity1139 and TA is a safe and successful procedure for the treatment of NLDO.

Safety and efficacy of adjunctive intranasal @entity1138 and XXXX in endonasal endoscopic dacryocystorhinostomy.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity82 :: ('MESH:D005355', 'Disease') :: ['fibrosis'] @entity2713 :: ('MESH:D014221', 'Chemical') :: ['triamcinolone'] @entity548 :: ('MESH:D006470', 'Disease') :: ['hemorrhage'] @entity1138 :: ('MESH:D016685', 'Chemical') :: ['mitomycin C'] @entity33 :: ('MESH:D052016', 'Disease') :: ['mucosal scarring', 'mucosal adhesion'] @entity532 :: ('MESH:D003925', 'Disease') :: ['complications'] @entity1139 :: ('CHEBI:27504', 'Chemical') :: ['MMC'] @entity479 :: ('D013256', 'Chemical') :: ['Steroid']
@entity2713 :: (MESH:D014221,Chemical) :: ['triamcinolone']
